Electrical Equipment & Parts
Compare Stocks
4 / 10Stock Comparison
PLPC vs ACCO vs BMI vs SPB
Revenue, margins, valuation, and 5-year total return — side by side.
Business Equipment & Supplies
Hardware, Equipment & Parts
Household & Personal Products
PLPC vs ACCO vs BMI vs SPB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Business Equipment & Supplies | Hardware, Equipment & Parts | Household & Personal Products |
| Market Cap | $1.69B | $375M | $3.61B | $1.83B |
| Revenue (TTM) | $697M | $1.55B | $917M | $2.79B |
| Net Income (TTM) | $34M | $74M | $142M | $105M |
| Gross Margin | 30.9% | 30.7% | 41.7% | 36.6% |
| Operating Margin | 8.0% | 7.9% | 20.0% | 4.1% |
| Forward P/E | 34.4x | 4.8x | 27.3x | 14.8x |
| Total Debt | $48M | $921M | $0.00 | $654M |
| Cash & Equiv. | $83M | $64M | $226M | $124M |
PLPC vs ACCO vs BMI vs SPB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Preformed Line Prod… (PLPC) | 100 | 696.1 | +596.1% |
| ACCO Brands Corpora… (ACCO) | 100 | 65.6 | -34.4% |
| Badger Meter, Inc. (BMI) | 100 | 200.4 | +100.4% |
| Spectrum Brands Hol… (SPB) | 100 | 166.1 | +66.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PLPC vs ACCO vs BMI vs SPB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PLPC has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 12.7%, EPS growth -4.8%, 3Y rev CAGR 1.7%
- 7.9% 10Y total return vs BMI's 253.6%
- 12.7% revenue growth vs ACCO's -8.5%
- +159.0% vs BMI's -45.0%
ACCO is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (4.8x vs 27.3x)
- 7.1% yield, vs BMI's 1.2%
BMI is the clearest fit if your priority is quality and efficiency.
- 15.5% margin vs SPB's 3.8%
- 14.5% ROA vs SPB's 3.0%, ROIC 34.5% vs 3.9%
SPB is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.82, yield 2.4%
- Lower volatility, beta 0.82, Low D/E 34.3%, current ratio 2.26x
- PEG 1.15 vs PLPC's 9.54
- Beta 0.82, yield 2.4%, current ratio 2.26x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% revenue growth vs ACCO's -8.5% | |
| Value | Lower P/E (4.8x vs 27.3x) | |
| Quality / Margins | 15.5% margin vs SPB's 3.8% | |
| Stability / Safety | Beta 0.82 vs PLPC's 1.58 | |
| Dividends | 7.1% yield, vs BMI's 1.2% | |
| Momentum (1Y) | +159.0% vs BMI's -45.0% | |
| Efficiency (ROA) | 14.5% ROA vs SPB's 3.0%, ROIC 34.5% vs 3.9% |
PLPC vs ACCO vs BMI vs SPB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PLPC vs ACCO vs BMI vs SPB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BMI leads in 2 of 6 categories
ACCO leads 1 • PLPC leads 1 • SPB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BMI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SPB is the larger business by revenue, generating $2.8B annually — 4.0x PLPC's $697M. BMI is the more profitable business, keeping 15.5% of every revenue dollar as net income compared to SPB's 3.8%. On growth, PLPC holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $697M | $1.6B | $917M | $2.8B |
| EBITDAEarnings before interest/tax | $73M | $177M | $218M | $214M |
| Net IncomeAfter-tax profit | $34M | $74M | $142M | $105M |
| Free Cash FlowCash after capex | $35M | $49M | $170M | $303M |
| Gross MarginGross profit ÷ Revenue | +30.9% | +30.7% | +41.7% | +36.6% |
| Operating MarginEBIT ÷ Revenue | +8.0% | +7.9% | +20.0% | +4.1% |
| Net MarginNet income ÷ Revenue | +4.9% | +4.8% | +15.5% | +3.8% |
| FCF MarginFCF ÷ Revenue | +5.0% | +3.2% | +18.5% | +10.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.7% | +8.3% | +7.6% | -3.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -8.2% | +2.4% | +9.6% | +48.8% |
Valuation Metrics
ACCO leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 9.2x trailing earnings, ACCO trades at a 81% valuation discount to PLPC's 48.4x P/E. Adjusting for growth (PEG ratio), BMI offers better value at 1.10x vs PLPC's 13.40x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.7B | $375M | $3.6B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $1.2B | $3.4B | $2.4B |
| Trailing P/EPrice ÷ TTM EPS | 48.39x | 9.23x | 25.60x | 20.37x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.44x | 4.83x | 27.28x | 14.84x |
| PEG RatioP/E ÷ EPS growth rate | 13.40x | — | 1.10x | 1.57x |
| EV / EBITDAEnterprise value multiple | 21.22x | 6.80x | 15.54x | 10.59x |
| Price / SalesMarket cap ÷ Revenue | 2.53x | 0.25x | 3.94x | 0.65x |
| Price / BookPrice ÷ Book value/share | 3.59x | 0.57x | 5.08x | 1.07x |
| Price / FCFMarket cap ÷ FCF | 50.75x | 7.37x | 21.30x | 11.04x |
Profitability & Efficiency
BMI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BMI delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $6 for SPB. PLPC carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACCO's 1.39x. On the Piotroski fundamental quality scale (0–9), ACCO scores 7/9 vs BMI's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.3% | +11.3% | +19.9% | +5.5% |
| ROA (TTM)Return on assets | +5.3% | +3.2% | +14.5% | +3.0% |
| ROICReturn on invested capital | +9.8% | +5.5% | +34.5% | +3.9% |
| ROCEReturn on capital employed | +11.0% | +6.1% | +24.1% | +4.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.10x | 1.39x | — | 0.34x |
| Net DebtTotal debt minus cash | -$35M | $856M | -$226M | $531M |
| Cash & Equiv.Liquid assets | $83M | $64M | $226M | $124M |
| Total DebtShort + long-term debt | $48M | $921M | $0 | $654M |
| Interest CoverageEBIT ÷ Interest expense | 39.48x | 2.50x | — | 3.33x |
Total Returns (Dividends Reinvested)
PLPC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PLPC five years ago would be worth $50,171 today (with dividends reinvested), compared to $6,075 for ACCO. Over the past 12 months, PLPC leads with a +159.0% total return vs BMI's -45.0%. The 3-year compound annual growth rate (CAGR) favors PLPC at 34.7% vs BMI's -2.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +63.2% | +12.1% | -30.3% | +31.7% |
| 1-Year ReturnPast 12 months | +159.0% | +22.8% | -45.0% | +30.1% |
| 3-Year ReturnCumulative with dividends | +144.2% | -4.4% | -8.2% | +14.2% |
| 5-Year ReturnCumulative with dividends | +401.7% | -39.3% | +39.5% | -7.8% |
| 10-Year ReturnCumulative with dividends | +794.9% | -35.1% | +253.6% | +11.9% |
| CAGR (3Y)Annualised 3-year return | +34.7% | -1.5% | -2.8% | +4.5% |
Risk & Volatility
Evenly matched — ACCO and SPB each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPB is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than PLPC's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACCO currently trades 94.6% from its 52-week high vs BMI's 47.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.58x | 1.33x | 0.87x | 0.82x |
| 52-Week HighHighest price in past year | $371.80 | $4.29 | $256.08 | $86.95 |
| 52-Week LowLowest price in past year | $132.15 | $2.81 | $112.09 | $49.99 |
| % of 52W HighCurrent price vs 52-week peak | +92.9% | +94.6% | +47.9% | +90.4% |
| RSI (14)Momentum oscillator 0–100 | 64.9 | 74.3 | 39.9 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 165K | 1.2M | 560K | 318K |
Analyst Outlook
Evenly matched — ACCO and BMI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PLPC as "Buy", ACCO as "Hold", BMI as "Hold", SPB as "Buy". Consensus price targets imply 97.0% upside for ACCO (target: $8) vs -20.4% for PLPC (target: $275). For income investors, ACCO offers the higher dividend yield at 7.07% vs PLPC's 0.24%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $275.00 | $8.00 | $172.14 | $85.00 |
| # AnalystsCovering analysts | 1 | 7 | 18 | 21 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +7.1% | +1.2% | +2.4% |
| Dividend StreakConsecutive years of raises | 3 | 0 | 33 | 1 |
| Dividend / ShareAnnual DPS | $0.83 | $0.29 | $1.47 | $1.86 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +4.0% | +0.4% | +17.8% |
BMI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACCO leads in 1 (Valuation Metrics). 2 tied.
PLPC vs ACCO vs BMI vs SPB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PLPC or ACCO or BMI or SPB a better buy right now?
For growth investors, Preformed Line Products Company (PLPC) is the stronger pick with 12.
7% revenue growth year-over-year, versus -8. 5% for ACCO Brands Corporation (ACCO). ACCO Brands Corporation (ACCO) offers the better valuation at 9. 2x trailing P/E (4. 8x forward), making it the more compelling value choice. Analysts rate Preformed Line Products Company (PLPC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PLPC or ACCO or BMI or SPB?
On trailing P/E, ACCO Brands Corporation (ACCO) is the cheapest at 9.
2x versus Preformed Line Products Company at 48. 4x. On forward P/E, ACCO Brands Corporation is actually cheaper at 4. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Spectrum Brands Holdings, Inc. wins at 1. 15x versus Preformed Line Products Company's 9. 54x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PLPC or ACCO or BMI or SPB?
Over the past 5 years, Preformed Line Products Company (PLPC) delivered a total return of +401.
7%, compared to -39. 3% for ACCO Brands Corporation (ACCO). Over 10 years, the gap is even starker: PLPC returned +794. 9% versus ACCO's -35. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PLPC or ACCO or BMI or SPB?
By beta (market sensitivity over 5 years), Spectrum Brands Holdings, Inc.
(SPB) is the lower-risk stock at 0. 82β versus Preformed Line Products Company's 1. 58β — meaning PLPC is approximately 94% more volatile than SPB relative to the S&P 500. On balance sheet safety, Preformed Line Products Company (PLPC) carries a lower debt/equity ratio of 10% versus 139% for ACCO Brands Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — PLPC or ACCO or BMI or SPB?
By revenue growth (latest reported year), Preformed Line Products Company (PLPC) is pulling ahead at 12.
7% versus -8. 5% for ACCO Brands Corporation (ACCO). On earnings-per-share growth, the picture is similar: ACCO Brands Corporation grew EPS 141. 5% year-over-year, compared to -5. 6% for Spectrum Brands Holdings, Inc.. Over a 3-year CAGR, BMI leads at 17. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PLPC or ACCO or BMI or SPB?
Badger Meter, Inc.
(BMI) is the more profitable company, earning 15. 5% net margin versus 2. 7% for ACCO Brands Corporation — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BMI leads at 20. 0% versus 4. 4% for SPB. At the gross margin level — before operating expenses — BMI leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PLPC or ACCO or BMI or SPB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Spectrum Brands Holdings, Inc. (SPB) is the more undervalued stock at a PEG of 1. 15x versus Preformed Line Products Company's 9. 54x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, ACCO Brands Corporation (ACCO) trades at 4. 8x forward P/E versus 34. 4x for Preformed Line Products Company — 29. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACCO: 97. 0% to $8. 00.
08Which pays a better dividend — PLPC or ACCO or BMI or SPB?
All stocks in this comparison pay dividends.
ACCO Brands Corporation (ACCO) offers the highest yield at 7. 1%, versus 0. 2% for Preformed Line Products Company (PLPC).
09Is PLPC or ACCO or BMI or SPB better for a retirement portfolio?
For long-horizon retirement investors, Badger Meter, Inc.
(BMI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 2% yield, +253. 6% 10Y return). Preformed Line Products Company (PLPC) carries a higher beta of 1. 58 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BMI: +253. 6%, PLPC: +794. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PLPC and ACCO and BMI and SPB?
These companies operate in different sectors (PLPC (Industrials) and ACCO (Industrials) and BMI (Technology) and SPB (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PLPC is a small-cap quality compounder stock; ACCO is a small-cap deep-value stock; BMI is a small-cap quality compounder stock; SPB is a small-cap quality compounder stock. ACCO, BMI, SPB pay a dividend while PLPC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.